Home/Pipeline/Afamelanotide

Afamelanotide

Xeroderma Pigmentosum (XP)

Clinical EvaluationSpecial Access Program (Stage 6 DNA Repair R&D)

Key Facts

Indication
Xeroderma Pigmentosum (XP)
Phase
Clinical Evaluation
Status
Special Access Program (Stage 6 DNA Repair R&D)
Company

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals is a global leader in photomedicine, translating scientific expertise in melanocortins into therapeutic and cosmetic solutions. The company's core focus is on developing treatments for severe photodermatoses, vitiligo, and exploring applications in DNA repair and central nervous system disorders. With a commercial-stage product generating record revenues, Clinuvel is strategically expanding its pipeline and luxury skincare division, PhotoCosmetics, to leverage its proprietary science across multiple markets.

View full company profile

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals is a global leader in photomedicine, translating scientific expertise in melanocortins into therapeutic and cosmetic solutions. The company's core focus is on developing treatments for severe photodermatoses, vitiligo, and exploring applications in DNA repair and central nervous system disorders. With a commercial-stage product generating record revenues, Clinuvel is strategically expanding its pipeline and luxury skincare division, PhotoCosmetics, to leverage its proprietary science across multiple markets.

View full company profile

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals is a global leader in photomedicine, translating scientific expertise in melanocortins into therapeutic and cosmetic solutions. The company's core focus is on developing treatments for severe photodermatoses, vitiligo, and exploring applications in DNA repair and central nervous system disorders. With a commercial-stage product generating record revenues, Clinuvel is strategically expanding its pipeline and luxury skincare division, PhotoCosmetics, to leverage its proprietary science across multiple markets.

View full company profile